Penn Medicine Provider
Ophthalmology
Albert M. Maguire, MD
4.9
(1234)
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian
View 2 additional locations

About me

  • F.M. Kirby Professor of Molecular Ophthalmology

Education and training

  • Medical School: Harvard Medical School
  • Residency: Yale-New Haven Hospital
  • Residency: Johns Hopkins Hospital
  • Fellowship: Beaumont Hospital, Royal Oak

What my patients think about me

Average Rating
4.9

1234 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
professional and knowledgeable
May 2025
5.0
5.0
caring
May 2025
5.0
5.0
short visit
April 2025
5.0
5.0
he is the best at what he does

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Maguire is a Penn Medicine physician.

Qualifications and experience

My research

Pierce, EA, Aleman, TS, Jayasundera, KT, Ashimaley, BS, Kim, E, Rashid, A, Jaskolka, MC, Myers, RL, Lam, BL, Bailey, ST, Comander, JI, Lauer, AK, Maguire, AM and Pennesi, ME Gene Editing for CEP290-Associated Retinal Degeneration , New England Journal of Medicine: 2024,Published online May 6, 2024


Tsui, JC, Huang, V, Kolmeyer, AM, Miller, CG, Mishkin, A and Maguire, AM Efficacy of maribavir in valganciclovir-resistant cytomegalovirus retinitis , Retina Cases Brief Rep, 18(2): 2024,164-167


Tsui JC, Wong, MB, Kim, BJ, Maguire, AM, Scoles, D, VanderBeek, BL, Brucker, AJ Appropriateness of ophthalmic symptoms triage by a popular online artificial intelligence chatbot , Eye (Lond), 37(17): 2023,692-3693


Ashtari, M, Cook, P, Lipin, M, Yu, Y, Ying, G-S, Maguire, AM, Bennett, J, Gee, J, Zhang, H Dynamic structural remodeling of the human visual system prompted by bilateral retinal gene therapy , Current Research in Neurobiology, 4: 2023,online 4 June 2023


Bennett, J and Maguire, AM Lessons Learned from the Development of the First FDA-Approved Gene Therapy Drug, Voretigene Neparvovec-rzyl; , Cold Spring Harb Perspect Med , 13: 2023,a041307


Tsui, JC, Wong, MB, Kim, BJ, Maguire, AM, Scoles, D, VanderBeek, BL, Brucker, AJ Appropriateness of ophthalmic symptoms triage by a popular online artifician intelligence chatbot , Eye (Lond), 32(e24): 2023


Andersen T, Miller CG, Xia T, Pulido JS, Brucker AJ, Maguire AM Vitreoretinal lymphoma presenting as frosted branch angiitis in a patient with diffuse large B-cell lymphoma. , Am J Ophthalmol Case Rep, 30: 2023,101838


Andersen, T, Miller, CG, Xia, T, Pulido, JS, Brucker, AJ, Maguire, AM Vitreoretinal lymphoma presenting as frosted branch angiitis in a patient with diffuse large B-cell lymphoma , Am J Ophthalmol Case Rep, 30: 2023,101838


Silson, EH, Baker, CI, Aleman, TS, Maguire, AM, Bennett, J and Ashtari, M Motion-selective areas V5/MT and MST appear resistant to deterioration in choroideremia , Neuroimage Clin, 38: 2023,103384


Bennett, J, Aleman, EMM, Maguire, HK, Weber, ML, Maguire, WM, Maja, A, O'Neil, EC, Maguire, AM, Miller, AJ and Aleman, TS Optimization and validation of a virtual reality orientation and ombility test for inherited retinal degenerations , Transl Vis Sci Technol, 12(1): 2023,28